A case of treatment for pulmonary infection caused by multidrug-resistant Acinetobacter baumannii .
Chenxia GuoShaohua XuWei YanPublished in: Respirology case reports (2024)
Acinetobacter baumannii is a major pathogen in hospital-acquired infections notorious for its strong acquired resistance and complex drug resistance mechanisms. Owing to the lack of effective drugs, the mortality rate of extensively drug-resistant A. baumannii pneumonia can reach as high as 65%. This article analyzes a case where a combination of cefoperazone-sulbactam, polymyxin B, and minocycline with rifampicin successfully treated XDR-AB pulmonary infection. Combination therapy is effective and has a particular clinical value.
Keyphrases
- acinetobacter baumannii
- drug resistant
- multidrug resistant
- combination therapy
- gram negative
- pulmonary hypertension
- klebsiella pneumoniae
- healthcare
- cardiovascular events
- risk factors
- cardiovascular disease
- type diabetes
- emergency department
- pulmonary tuberculosis
- intensive care unit
- coronary artery disease
- escherichia coli
- acute care
- community acquired pneumonia
- drug induced